XML 76 R5.htm IDEA: XBRL DOCUMENT v3.2.0.727
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash flows from operating activities:    
Net income (loss) $ (12,161) $ (25,464)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 8,619 9,138
Stock-based compensation expense 4,546 1,879
Inventory impairments and option contract abandonments 249 2,921
Deferred and other income tax (benefit) expense (731) 16
Change in allowance for doubtful accounts 47 (373)
Equity in loss (income) of unconsolidated entities and marketable securities 1,453 (221)
Cash distributions of income from marketable securities and unconsolidated entities 99 567
Loss on extinguishment of debt 0 2,670
Changes in operating assets and liabilities:    
Increase in accounts receivable (10,500) (6,284)
Increase in income tax receivable (216) (1,941)
Increase in inventory (245,169) (260,982)
Increase in other assets (2,287) (626)
Increase in trade accounts payable 20,826 635
Decrease in other liabilities (2,716) (11,191)
Other changes (199) (337)
Net cash used in operating activities (238,140) (289,593)
Cash flows from investing activities:    
Capital expenditures (11,756) (8,984)
Investments in unconsolidated entities (2,651) (4,567)
Proceeds from sale of unconsolidated entities and marketable securities 24,245 187
Increases in restricted cash (3,806) (10,081)
Decreases in restricted cash 28,936 1,096
Net cash provided by (used in) investing activities 34,968 (22,349)
Cash flows from financing activities:    
Repayment of debt (11,934) (305,085)
Proceeds from issuance of new debt 0 325,000
Borrowings from credit facility 50,000 0
Repayment of borrowings from credit facility (30,000) 0
Debt issuance costs (126) (5,504)
Other financing activities (170) (446)
Net cash provided by financing activities 7,770 13,965
Decrease in cash and cash equivalents (195,402) (297,977)
Cash and cash equivalents at beginning of period 324,154 $ 504,459
Cash and cash equivalents at end of period $ 128,752